AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company UK:AZN said its lead product ...

Learn more The best weight loss foods for cats are formulated to help cats lose weight safely. They typically have fewer calories, less fat, and more nutrients per serving than other formulas.

and persistent effects in terms of weight loss (up to -8.3% from baseline) were also observed on the 57th day of follow-up, 4 weeks after the administration of the last pill. Based on a ...

(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...

LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...

Data reported earlier Monday from Viking Therapeutics (NASDAQ:VKTX) on its weight loss medicine VK2735 indicates ... in both as an injectable and in pill form, is most closely related to Lilly's ...

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill. The San Diego-based company’s stock ...

The answer appears in natural weight loss supplements that complement your lifestyle and meet your every need, trimming inches and shedding pounds. Weight loss needs a comprehensive approach that ...

AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo-Swedish drugmaker's closely watched weight loss pill, AZD5004 ...

You're not alone. In today's saturated market, finding weight loss supplements that genuinely deliver results without unwanted side effects feels like searching for a needle in a haystack.

(LLY), are working to develop a weight-loss pill. Jefferies is confident Viking's stock still has plenty of upside. The research team has a $110 price target on the stock, which is 49% above its ...

Viking Therapeutics Inc.’s stock was up up as much as 3.8% early Friday as excitement continued to build about data on the oral weight-loss drug the company will present at the upcoming Obesity ...